Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

01 January 2001

Injury in vascular surgery--the intimal hyperplastic response.

Tomasz Zubilewicz, Jacek Wroński, Armand Bourriez, Piotr Terlecki, Anne M Guinault, Brigitte Muscatelli-Groux, Jerzy Michalak, Didier Méllière, Jean P Becquemin, Eric Allaire

Med Sci Monit 2001; 7(2): RA316-324 :: ID: 421141

Abstract

Intimal hyperplasia is extensively studied in order to improve arterialreconstruction outcome. The mechanisms leading to stenosis or restenosis may vary according to the techniqueused for arterial reconstruction. Lesions are mostly made of an accumulation of smooth muscle cells andfibroblasts, with only sparse inflammatory cells. The accumulated material reduces the graft lumen andultimately induces thrombosis. Intimal hyperplasia with smooth muscle cell and matrix accumulation isthe prominent feature in all these situations with evidences of intense cell proliferation and cell death.The purpose of this review is to present the biology of intimal hyperplastic response based on the recentlypublished data. Experiments in the rabbits have shown that the vein wall thickening is mainly regulatedby the tangential wall stress which is applied transversely to the vein wall as a blood pressure. Experimentsin the rat carotid artery balloon injury suggested that heparin could be used as a treatment to preventintimal hyperplasia. Treatments for preventing restenosis after angioplasty or stenoses development inbypasses have been disappointing clinical evaluation suffers from insufficient prospective randomizedstudies. Intimal hyperplasia is the major cause of failure after arterial reconstruction. The biologyof intimal hyperplasia is complex, and treatment disappointing. Some types of hyperplasia may need tobe preserved in order to prevent functional atrophy and aneurysmal dilatation of vein grafts.

Keywords: smooth muscle cells, intimal hyperplasia, vessel injury

Add Comment 0 Comments

Editorial

01 May 2024 : Editorial  

Editorial: First Regulatory Approval for Adoptive Cell Therapy with Autologous Tumor-Infiltrating Lymphocytes (TILs) – Lifileucel (Amtagvi)

Dinah V. Parums

DOI: 10.12659/MSM.944927

Med Sci Monit 2024; 30:e944927

In Press

11 Mar 2024 : Clinical Research  

Enhancement of Frozen-Thawed Human Sperm Quality with Zinc as a Cryoprotective Additive

Med Sci Monit In Press; DOI: 10.12659/MSM.942946  

0:00

12 Mar 2024 : Database Analysis  

Risk Factors of Age-Related Macular Degeneration in a Population-Based Study: Results from SHIP-TREND-1 (St...

Med Sci Monit In Press; DOI: 10.12659/MSM.943140  

0:00

12 Mar 2024 : Clinical Research  

Preoperative Blood Transfusion Requirements for Hemorrhoidal Severe Anemia: A Retrospective Study of 128 Pa...

Med Sci Monit In Press; DOI: 10.12659/MSM.943126  

0:00

12 Mar 2024 : Clinical Research  

Tissue Inhibitors of Metalloproteinase 1 (TIMP-1) and 3 (TIMP-3) as New Markers of Acute Kidney Injury Afte...

Med Sci Monit In Press; DOI: 10.12659/MSM.943500  

0:00

Most Viewed Current Articles

17 Jan 2024 : Review article  

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

14 Dec 2022 : Clinical Research  

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990

0:00

16 May 2023 : Clinical Research  

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750